Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: BioPharmaceuticals _ Orphan & Rare Diseases
Mendra

Organization & Developments: Mendra

Parents

*Focuses on acquiring, developing, and commercializing therapies for rare diseases with high unmet medical needs.
*Mendra aims to "modernize" rare disease drug development by acting as an aggregator for assets that have been stalled or deprioritized by larger firms.
2026: Mendra raises $82M Series A for rare disease therapeutics
Mendra uses artificial intelligence to accelerate patient identification, improve clinical trial enrollment, and support access across international markets that often limits reach in rare disease drug development.